SCHEMBL8082292

SCHEMBL8082292

CNC(C)C(ON1CCCC1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.43
CYP3A4 P08684 5/20 0.43
CYP2C9 P11712 5/20 0.43
CYP2C19 P33261 5/20 0.43
CHRM2 P08172 1/20 0.43
ADRA1A P35348 1/20 0.43
RGS12 O14924 1/20 0.43
GLA P06280 1/20 0.43
PKM P14618 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
ADRA2C P18825 1/20 0.43
NFKB1 P19838 1/20 0.43
HTR2A P28223 1/20 0.43
THPO P40225 1/20 0.43
GNAI1 P63096 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515589 0.80 CYP2D6 (0.40) CYP2D6CYP3A4CYP2C9CYP2C19ADRA2C
SCHEMBL7480934 0.74 CYP2D6 (0.47) CYP2D6CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL14224817 0.73 CYP3A4 (0.53) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
SCHEMBL186191 0.73 CYP3A4 (0.53) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
SCHEMBL14541701 0.73 CYP3A4 (0.53) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
SCHEMBL28042294 0.73 CYP2D6 (0.50) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
Hydrochloric Acid SCHEMBL29424742 0.73 CYP2D6 (0.46) CYP2D6CYP3A4CYP2C9CYP2C19TSHR
SCHEMBL7051224 0.72 ADRA2C (0.52) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
SCHEMBL354931 0.72 ADRA2C (0.57) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2
SCHEMBL9410650 0.72 HTR2A (0.52) CYP2D6CYP3A4CYP2C9CYP2C19CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828703-B1 ASYMMETRIC SYNTHESIS OF (-) 6-CHLORO-4-CYCLOPROPYL-ETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE MERCK & CO INC (US) 2000-09-20 EP disclosed
EP-0805790-B1 IMPROVED SYNTHESIS OF CYCLOPROPYLACETYLENE MERCK & CO INC (US) 1999-11-24 EP disclosed
EP-0828703-A1 ASYMMETRIC SYNTHESIS OF (-) 6-CHLORO-4-CYCLOPROPYL-ETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE Merck & Co., Inc. (US) 1998-03-18 EP disclosed
US-5698741-A HIV REVERSE TRANSCRIPTASE INHIBITOR MERCK & CO. INC. (US) 1997-12-16 US disclosed
EP-0805790-A1 IMPROVED SYNTHESIS OF CYCLOPROPYLACETYLENE Merck & Co., Inc. (US) 1997-11-12 EP disclosed
US-5663467-A BASIC REACTION OF 5-HALO-1-PENTYNE IN APROTIC SOLVENT, HEATING AND CYCLIZATION THEN QUENCHING MERCK & CO., INC. (US) 1997-09-02 US disclosed
US-5633405-A REACTING SUBSTITUTED NOREPHEDRINE WITH CYCLOPROPYLACETYLENE AND LITHIATING AGENT IN APROTIC SOLVENT, MIXING WITH ANILINE TRIFLUOROMETHYL KETONE, QUENCHING WITH PROTON SOURCE MERCK & CO., INC. (US) 1997-05-27 US disclosed
WO-1996037457-A1 ASYMMETRIC SYNTHESIS OF (-) 6-CHLORO-4-CYCLOPROPYL-ETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE MERCK & CO., INC. (US) 1996-11-28 WO disclosed
WO-1996022955-A1 IMPROVED SYNTHESIS OF CYCLOPROPYLACETYLENE MERCK & CO., INC. (US) 1996-08-01 WO disclosed